Results seem good. I believe that they were waiting for the trials to be finished and the Cohort Review Comittee to up the dosage to 100 µg before commencing the study with Pembrolizumab. Explains the delay in beginning that study.
- Forums
- ASX - By Stock
- IMU
- Ann: Final HER-Vaxx Phase 2 Trial Overall Survival Results
Ann: Final HER-Vaxx Phase 2 Trial Overall Survival Results, page-58
-
- There are more pages in this discussion • 382 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $389.5M |
Open | High | Low | Value | Volume |
5.3¢ | 5.4¢ | 5.3¢ | $67.94K | 1.281M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 500166 | 5.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.4¢ | 3755253 | 19 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
22 | 500166 | 0.053 |
37 | 3116501 | 0.052 |
33 | 4318550 | 0.051 |
50 | 4652179 | 0.050 |
17 | 2263068 | 0.049 |
Price($) | Vol. | No. |
---|---|---|
0.054 | 3755253 | 19 |
0.055 | 1902466 | 21 |
0.056 | 2935755 | 12 |
0.057 | 871993 | 10 |
0.058 | 1181326 | 9 |
Last trade - 11.09am 16/08/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online